NEW YORK, N.Y. — The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world’s first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic’s medical fees. CGH is an acronym for Comparative Genomic Hybridization - a genetic process that analyzes the chromosomal integrity of the egg or embryo prior to it being transferred to a woman’s uterus in the course of In Vitro Fertilization. GH reveals whether an egg or embryo has the correct number of chromosomes. Too many or too few (referred to as “aneuploidy”) will result in either a non-viable embryo, a miscarriage or, if implanted and carried to term, a birth defect. Because aneuploidy is the most common cause of IVF failure, identifying viable embryos for transfer to the uterus can significantly boost birthrates for IVF.
“We can confidently share the financial risks of IVF because of our extraordinary successes using CGH to select one or two of the best embryos,” explained Dr. Geoffrey Sher, Executive Medical Director of the Sher Institutes. “This is why, using CGH, our success rates are high, while our triplet rates are almost nil.”
Tags : ivf
Categories : In Vitro Fertilization
RSS feed for comments on this post
No Response